Cipher Pharmaceuticals Inc. (CPHRF)
OTCMKTS · Delayed Price · Currency is USD
11.82
+0.08 (0.70%)
Sep 12, 2025, 3:55 PM EDT
Cipher Pharmaceuticals Market Cap
Cipher Pharmaceuticals has a market cap or net worth of $299.60 million as of September 12, 2025. Its market cap has decreased by -11.02% in one year.
Market Cap
299.60M
Enterprise Value
313.49M
Revenue
47.59M
Ranking
n/a
PE Ratio
24.67
Stock Price
$11.82
Market Cap Chart
Since February 25, 2004, Cipher Pharmaceuticals's market cap has increased from 58.00M to 299.60M, an increase of 416.58%. That is a compound annual growth rate of 7.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 299.60M | 17.64% |
| Dec 31, 2024 | 254.68M | 152.73% |
| Dec 29, 2023 | 100.77M | 41.37% |
| Dec 30, 2022 | 71.28M | 94.22% |
| Dec 31, 2021 | 36.70M | 86.01% |
| Dec 31, 2020 | 19.73M | -36.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 781.22M |
| Elite Pharmaceuticals | 739.37M |
| Tian'an Technology Group | 675.94M |
| Glass House Brands | 585.86M |
| CytoDyn | 424.27M |
| Northwest Biotherapeutics | 378.39M |
| American Oncology Network | 353.52M |